TRS Ex Parte –GC Docket No. 10-51 12/1/10—Sorenson and Madison Dearborn Partners met with Paul de Sa of the OSP to discuss VRS issues. Sorenson and Madison Dearborn discussed the role of customer relationship between the default user and VRS provider in ensuring that deaf and hard-of-hearing Americans have functionally equivalent VRS services. Sorenson and […]

TRS CG Docket No. 10-210 11/29/10—Late-filed replies on the implementation of the requirement for a National Deaf-Blind Equipment Distribution Program, per Section 105 of the 21st Century Communications and Video Accessibility Act of 2010. Public Notice Inclusive Technologies

TRS Ex Parte—CG Docket No. 10-51 10/19/10—Hamilton Relay met with Karen Peltz Strauss of the CGB to discuss its request for clarification of a February 2010 Declaratory Ruling. Hamilton Relay reiterated its support of numerous providers who believe that various calls involving more than one Communications Assistant (CA) are compensable relay calls, and the effect […]

The Deal Magazine By Richard Morgan Published October 1, 2010 at 12:37 PM Public trust and private equity are at odds almost by definition. But when it comes to serving American citizens with hearing or speech disabilities, they’re at loggerheads. Witness the schism between the Federal Communications Commission and the market leader in video relay […]

TRS NPRM—CG Docket No. 03-123 9/17/10—The FCC released an NPRM seeking comment on the steps the FCC should take to improve assignment of telephone numbers associated with Internet-based Telecommunications Relay Service, specifically Video Relay Service and IP Relay. Comments due 30 days after publication in the Federal Register; replies due 45 days after publication.

TRS 8/27/10—Chairman Genachowski responded to a number of letters from members of Congress regarding VRS issues. Chairman Genachowski said the rates adopted in the June 28th Order ensure VRS providers recover from the VRS Fund only the reasonable costs caused by provision of VRS service. Chairman Genachowski also said the VRS NOI poses questions that […]

Nutritional Value Per Serving

One of the most controversial products available in the market today is the HGH growth hormone. Researchers believed that such discovery of the so-called “fountain of youth” is an awesome breakthrough to enhance the quality of living. On the contrary, some health professionals have argued about the potential risks of taking an HGH dose which could lead to fatal diseases and cancer. However, none of these sides can provide solid evidences due to the lack of related studies. The benefits as well as the potential negative effects linked with HGH supplements are still a mystery, and the final verdict is left to you, the consumer.

After a couple of weeks away from yoga, I wanted to ease back into the practice. So I went to a restorative class this morning. It was a new studio, and I wandered back to the office to sign in as “Drop In.”

“I’m a drop in too,” I heard another woman say. “This is restorative yoga, right?” the woman continued. “The kind where you lay around and rest?”

Erectile dysfunction (ED) is easily the worst woe that a man will ever encounter as he no longer has the capacity to please both himself and his partner. Fortunately, ED medications are aplenty with tadalafil being the most popular amongst couples. However, when it comes to buying ED medications, is it better to go for branded or generic?

If you are not familiar with generic drugs, the name that identifies a generic drug is usually the active ingredient that the treatment has. For generic tadalafil, it means that tadalafil is the active ingredient of the drug. Usually, generic drugs are derived from branded drugs, the likes that had spent a lot of money in the research and development of the medication. Normally, they are given several years of rights as sole maker and distributor of the drug to make up for the cost of the drug’s R&D. In the case of generic tadalafil, it is Eli Lilly that did research as well as manufacturing of the drug Cialis – the branded version of generic tadalafil. Like all drugs though, no manufacturer has sole rights to the making and distribution of the medication for a very long time which is why the ingredients used in the making of the drug are released and generic drug manufacturers are able to copy them and resell the drug for their own, provided of course they pay royalty as well as sell the drug only as generic in name. Read more…